SENATE RESOLUTION NO. 684
         WHEREAS, Cancer remains one of the most pressing public
  health concerns in the United States, and it is estimated that in
  2019, more than 1.7 million Americans will be diagnosed with
  cancer and over 600,000 will die from the disease; and
 
         WHEREAS, One in every two men and one in every three women
  in the United States will learn that they have cancer during his
  or her lifetime; cancer is currently the second leading cause of
  death in the nation, and it is on track to become the number one
  disease-related killer; among some racial and ethnic minorities,
  as well as low-income and elderly populations, it exacts an even
  greater toll in terms of incidence, prevalence, and mortality; and
 
         WHEREAS, Cancer is projected to cost the United States
  approximately $170 billion in 2019, and the economic burden of
  the disease is expected to rise along with the number of
  cancer-related deaths; and
 
         WHEREAS, Advancements in understanding the causes,
  mechanisms, diagnoses, treatment, and prevention of cancer have
  led to cures for many types and have converted others into
  manageable chronic conditions; effective therapies and screening
  tools for certain forms of cancer remain elusive, however, and
  some, such as pancreatic, liver, lung, ovarian, and brain cancer,
  continue to have extraordinarily high mortality rates; and
 
         WHEREAS, Partnerships among research scientists, cancer
  survivors, patient advocates, philanthropic organizations,
  government entities, and the general public have resulted in
  breakthroughs that have increased early detection and survival
  rates and improved the quality of life of cancer sufferers; and
 
         WHEREAS, The Cancer Prevention Research Institute of Texas
  is the second-largest source of cancer research after the
  National Cancer Institute; since its establishment in 2007,
  CPRIT has recruited over 170 researchers to the state, created
  more than 10,000 permanent jobs, increased biotech investment in
  the state by 11 percent, and detected over 15,000 cancer
  precursors and 3,500 cancers; CPRIT has additionally facilitated
  109 clinical trials and studies that have involved some 13,000
  patients, and the $2 billion that the State of Texas has invested
  through CPRIT to date has produced $2.7 billion in outside
  investment; and
 
         WHEREAS, The State of Texas is fortunate to have scientists
  and researchers of exceptional skill who are on the front lines
  of the fight against cancer, and National Cancer Research Month
  in May provides an opportune time to express our support for
  their lifesaving efforts; now, therefore, be it
         RESOLVED, That the Senate of the State of Texas, 86th
  Legislature, hereby recognize May 2019 as Cancer Research Month
  in Texas and honor the invaluable contributions of researchers in
  the Lone Star State and beyond for their dedication to ending the
  cancer epidemic.
 
  Watson, Huffman,
  Nelson          
   
   
   
    ________________________________ 
        President of the Senate
     
        I hereby certify that the
    above Resolution was adopted by
    the Senate on May 2, 2019.
   
   
   
    ________________________________ 
        Secretary of the Senate
   
   
   
    ________________________________ 
         Member, Texas Senate
   
   
   
    ________________________________ 
         Member, Texas Senate
   
   
   
    ________________________________ 
         Member, Texas Senate